-The Times of India WASHINGTON: India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight. Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the ''poster child for price gouging in...

-The Hindu India spends less of its GDP on health than some of the world’s poorest countries’ Every government hospital serves an estimated 61,000 people in India, with one bed for every 1833 people, new official data shows. In undivided Andhra Pradesh, every government hospital serves over 3 lakh patients while in Bihar, there is only one bed for every 8800 people. Union Minister for Health J.P. Nadda released the National Health Profile...

-The Times of India NEW DELHI: Air pollution may be posing a rising health risk in India as the number of cases of acute respiratory infection have risen by 5 million since 2012 even though deaths have declined in the same period, government data released on Tuesday evening show. Cases of ARI have been rising even before 2012 though deaths began to decline since that year. The government report notes the strong...

-The Times of India NEW DELHI: Even as the government is still deliberating on larger pictorial warnings on packs of tobacco products, 40% of Indian adults are exposed to second hand tobacco smoke at home. These are people who do not smoke themselves but are vulnerable to various diseases because someone smokes at home, showed a latest assessment by the World Health Organization, highlighting risks of second hand smoking and the need...

-The Times of India NEW DELHI: cancer medicines and stents may soon be available at a substantially lower price. The health ministry is working on a model to procure such drugs in bulk at a negotiated price and supply them to hospitals and consumers through its own retail system like 'Jan Aushadhi' stores. . The idea is to bring down prices of expensive cancer drugs and stents while not putting pressure on...